Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (8134)	12/28/1998 7:46:00 AM
From: jackie	Read Replies (1) \| Respond to of 17367

To all, Looks like some increased public spending in the area of bacterial resistance to antibiotics. See post at Message 6988779 It would appear this money will spent at the reporting level, where the raw data for epidemiological study begins. George, I know you spent a lot of time trying to draw some conclusions on death rates from public domain data on mortality in Great Britain. Rather difficult to do this without the data feeds. Evidently it is felt this country has a weakness at the county level in reporting to CDC the information they need to do their job. Regards, Jack